Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 859

1.

ACG clinical guidelines: diagnosis and management of celiac disease.

Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of Gastroenterology.

Am J Gastroenterol. 2013 May;108(5):656-76; quiz 677. doi: 10.1038/ajg.2013.79. Epub 2013 Apr 23.

2.

Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(21):1-111. Epub 2010 Dec 1.

3.

Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.

Kurppa K, Paavola A, Collin P, Sievänen H, Laurila K, Huhtala H, Saavalainen P, Mäki M, Kaukinen K.

Gastroenterology. 2014 Sep;147(3):610-617.e1. doi: 10.1053/j.gastro.2014.05.003. Epub 2014 May 13.

PMID:
24837306
4.

Monitoring nonresponsive patients who have celiac disease.

Krauss N, Schuppan D.

Gastrointest Endosc Clin N Am. 2006 Apr;16(2):317-27. Review.

PMID:
16644460
5.

Celiac disease or non-celiac gluten sensitivity? An approach to clinical differential diagnosis.

Kabbani TA, Vanga RR, Leffler DA, Villafuerte-Galvez J, Pallav K, Hansen J, Mukherjee R, Dennis M, Kelly CP.

Am J Gastroenterol. 2014 May;109(5):741-6; quiz 747. doi: 10.1038/ajg.2014.41. Epub 2014 Mar 11.

PMID:
24619056
6.

Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?

Bannister EG, Cameron DJ, Ng J, Chow CW, Oliver MR, Alex G, Catto-Smith AG, Heine RG, Webb A, McGrath K, Simpson D, Hardikar W.

Am J Gastroenterol. 2014 Sep;109(9):1478-83. doi: 10.1038/ajg.2014.200. Epub 2014 Jul 29.

PMID:
25070050
7.

[Celiac disease].

Malamut G, Cellier C.

Rev Med Interne. 2010 Jun;31(6):428-33. doi: 10.1016/j.revmed.2009.04.009. Epub 2010 Mar 31. French.

PMID:
20359791
8.

Celiac sprue.

Cárdenas A, Kelly CP.

Semin Gastrointest Dis. 2002 Oct;13(4):232-44. Review.

PMID:
12462708
9.

Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.

Bucci C, Zingone F, Russo I, Morra I, Tortora R, Pogna N, Scalia G, Iovino P, Ciacci C.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1294-1299.e1. doi: 10.1016/j.cgh.2013.04.022. Epub 2013 Apr 30.

PMID:
23639603
10.

Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.

Kurppa K, Collin P, Viljamaa M, Haimila K, Saavalainen P, Partanen J, Laurila K, Huhtala H, Paasikivi K, Mäki M, Kaukinen K.

Gastroenterology. 2009 Mar;136(3):816-23. doi: 10.1053/j.gastro.2008.11.040. Epub 2008 Nov 24.

PMID:
19111551
11.

Celiac disease: risk assessment, diagnosis, and monitoring.

Setty M, Hormaza L, Guandalini S.

Mol Diagn Ther. 2008;12(5):289-98. Review.

PMID:
18803427
12.

[Clinical features and diagnosis of celiac disease].

Stein J.

Internist (Berl). 2006 Sep;47(9):929-37; quiz 938. German.

PMID:
16912874
13.

Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.

Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R.

Clin Gastroenterol Hepatol. 2007 Jul;5(7):844-50; quiz 769. Epub 2007 Jun 5.

PMID:
17553753
14.

New strategies for diagnosis and management of celiac disease.

Westerberg DP, Gill JM, Dave B, DiPrinzio MJ, Quisel A, Foy A.

J Am Osteopath Assoc. 2006 Mar;106(3):145-51. Review.

PMID:
16585382
15.

Celiac disease.

Holtmeier W, Caspary WF.

Orphanet J Rare Dis. 2006 Mar 1;1:3. Review.

16.

Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?

Lindfors K, Mäki M, Kaukinen K.

Autoimmun Rev. 2010 Sep;9(11):744-9. doi: 10.1016/j.autrev.2010.06.003. Epub 2010 Jun 12. Review.

PMID:
20547248
17.

Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease.

Lähdeaho ML, Mäki M, Laurila K, Huhtala H, Kaukinen K.

BMC Gastroenterol. 2011 Nov 24;11:129. doi: 10.1186/1471-230X-11-129.

18.

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.

Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.

BMC Immunol. 2008 Feb 29;9:6. doi: 10.1186/1471-2172-9-6.

19.

Celiac disease: diagnosis and management.

Pelkowski TD, Viera AJ.

Am Fam Physician. 2014 Jan 15;89(2):99-105.

20.

Gluten-free diet: the medical and nutrition management of celiac disease.

See J, Murray JA.

Nutr Clin Pract. 2006 Feb;21(1):1-15. Review.

PMID:
16439765
Items per page

Supplemental Content

Write to the Help Desk